Patent · US Active

PET-imaging immunomodulators

US11103605B2 · kind B2 · utility

3Cited by
12References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2017
Grant dateAug 31, 2021
Priority date
Expiry dateMay 17, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the synthesis and use of 18F-labeled millamolecules for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.